SCHEMBL5865255

SCHEMBL5865255

O=C1c2ccccc2C(=O)N1Cc1cccc(C2=Cc3ccccc3CC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PKM P14618 1/20 0.45
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.40
RECQL P46063 1/20 0.40
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
TGFBR1 P36897 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
CYP1B1 Q16678 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864777 0.78 CYP11B1 (0.42) CYP19A1CYP11B1CYP11B2NISCHGPR84
Hydrochloric Acid SCHEMBL5865474 0.77 CYP11B1 (0.41) CYP19A1CYP11B1CYP11B2NISCHGPR84
SCHEMBL8377843 0.75 ALDH1A1 (0.68) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1072206 0.68 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL5028346 0.68 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL23796073 0.68 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL378947 0.68 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL2766815 0.68 MEN1 (0.58) ALDH1A1MEN1KMT2APKMMAPT
SCHEMBL4882922 0.68 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1632535 0.68 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C ALDH1A1 832/4885MEN1 2517/4885KMT2A 823/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C ALDH1A1 832/4885MEN1 2517/4885KMT2A 823/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C ALDH1A1 1046/4885MEN1 2586/4885KMT2A 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.